Gentamicin delivery to the inner ear: Does endolymphatic hydrops matter?
- PMID: 30440019
- PMCID: PMC6237362
- DOI: 10.1371/journal.pone.0207467
Gentamicin delivery to the inner ear: Does endolymphatic hydrops matter?
Abstract
Introduction: Middle ear application of gentamicin is a common medical treatment for uncontrolled Ménière's disease. The objective of the study was to evaluate the impact of endolymphatic hydrops on inner ear delivery.
Methods: Perilymph gentamicin concentrations and correlation with endolymphatic hydrops in an animal model were assessed. A group of 24 guinea pigs was submitted to surgical obstruction of the endolymphatic sac and duct of the right ear. Gentamicin was applied either to the right ear's round window niche or through a transtympanic injection. Perilymph specimens were collected at different times. Histologic morphometry was used to evaluate both turn-specific and overall hydrops degree.
Results: In animals with endolymphatic hydrops, lower concentrations of gentamicin were observed after 20 or 120 minutes of exposure and in both types of administration, when compared to controls. This difference reached statistical significance in the round window niche application group (Mann-Whitney, p = 0,007). A negative correlation between perilymphatic gentamicin concentration and hydrops degree could be observed in both groups, after 120 minutes of exposure (Spearman correlation, round window niche p<0,001; TT p = 0,005).
Conclusions: The study indicates that the endolymphatic hydrops degree has a negative interference on the delivery of gentamicin into the inner ear following middle ear application.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandala M, et al. Diagnostic criteria for Meniere's disease. Journal of vestibular research: equilibrium & orientation. 2015;25(1):1–7. - PubMed
-
- Pender DJ. Endolymphatic hydrops and Meniere's disease: a lesion meta-analysis. The Journal of laryngology and otology. 2014;128(10):859–65. 10.1017/S0022215114001972 - DOI - PubMed
-
- Merchant SN, Adams JC, Nadol JB Jr. Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops? Otology & neurotology: official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2005;26(1):74–81. - PubMed
-
- Foster CA, Breeze RE. Endolymphatic hydrops in Meniere's disease: cause, consequence, or epiphenomenon? Otology & neurotology: official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2013;34(7):1210–4. - PubMed
-
- Marques PS, Dias CC, Perez-Fernandez N, Spratley J. Instrumental head impulse test changes after intratympanic gentamicin for unilateral definite Meniere's disease: A systematic review and meta-analysis. Auris, nasus, larynx. 2018;45(5):943–51. 10.1016/j.anl.2018.01.001 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
